Page 74 - Express Scripts News Today

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and...

The settlement identified alleged failures over prescriptions filled at CVS locations in Springfield, New Bedford, Boston, and Worcester.

While testifying at a US Senate committee hearing on the price of insulin this week, leaders of major insulin producers and pharmacy benefit managers blamed each other for the high cost of insulin

For two decades, patients and physicians eagerly awaited a lower-cost version of the world’s bestselling drug, Humira, while its maker, AbbVie, fought off potential competitors by building a wall of

Operator: Ladies and gentlemen, thank you for standing by. And welcome to the GoodRx First Quarter 2023 Earnings Call. As a reminder, todays conference is being recorded.

Members of the U.S. Senate Committee on Health, Education, Labor and Pensions conducted a hearing on May 10 to investigate insulin affordability and what caused prices to increase during the past decade. Executives from the three leading insulin manufacturers and the three leading pharmacy benefit managers (PBMs) in the U.S. provided testimony and answered a wide range of questions from

"We want to know why there are Americans who are dying, or are becoming much sicker than they should, because they can't afford the medicine they need," said the Vermont Senator.

A Senate HELP Committee hearing left much to be desired when it comes to clarity on high drug prices. But some experts believe the needle is still shifting on change.

WASHINGTON — U.S. senators sparred with pharmaceutical companies and pharmacy benefit managers during a Wednesday hearing on the costs of insulin and other prescription medications. Louisiana Sen. …

As for when the chaos will end, it depends on who you ask. Leadership is sticking to the script, insisting that, really, seriously, Friday is the last day.